These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 37742293

  • 1. Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes.
    Lai W, Luo D, Li Y, Li Y, Wang Q, Hu Z, Ye Z, Peng H.
    FASEB J; 2023 Oct; 37(10):e23175. PubMed ID: 37742293
    [Abstract] [Full Text] [Related]

  • 2. Qizhi Jiangtang capsule activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways.
    Zhaoan G, Lina S, Yingying L, Ruifeng LI, Chong L, Ke D, Jing S, Jun S.
    J Tradit Chin Med; 2023 Aug; 43(4):667-675. PubMed ID: 37454251
    [Abstract] [Full Text] [Related]

  • 3. Sirt6 ameliorates high glucose-induced podocyte cytoskeleton remodeling via the PI3K/AKT signaling pathway.
    Zhang Z, Huang H, Tao Y, Liu H, Fan Y.
    Ren Fail; 2024 Dec; 46(2):2410396. PubMed ID: 39378103
    [Abstract] [Full Text] [Related]

  • 4. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
    Yang F, Qu Q, Zhao C, Liu X, Yang P, Li Z, Han L, Shi X.
    Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
    [Abstract] [Full Text] [Related]

  • 5. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway.
    Jin J, Gong J, Zhao L, Li Y, He Q.
    Acta Biochim Pol; 2021 Oct 14; 68(4):619-625. PubMed ID: 34648253
    [Abstract] [Full Text] [Related]

  • 6. Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress.
    Li D, Lu Z, Xu Z, Ji J, Zheng Z, Lin S, Yan T.
    Biosci Rep; 2016 Aug 14; 36(4):. PubMed ID: 27129295
    [Abstract] [Full Text] [Related]

  • 7. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
    Jin D, Liu F, Yu M, Zhao Y, Yan G, Xue J, Sun Y, Zhao D, Li X, Qi W, Wang X.
    J Ethnopharmacol; 2022 Jul 15; 293():115246. PubMed ID: 35398500
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.
    Zhao X, Chen Y, Tan X, Zhang L, Zhang H, Li Z, Liu S, Li R, Lin T, Liao R, Zhang Q, Dong W, Shi W, Liang X.
    J Pathol; 2018 Jun 15; 245(2):235-248. PubMed ID: 29570219
    [Abstract] [Full Text] [Related]

  • 11. Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K/AKT/mTOR pathway in diabetic kidney disease.
    Dong R, Zhang X, Liu Y, Zhao T, Sun Z, Liu P, Xiang Q, Xiong J, Du X, Yang X, Gui D, Xu Y.
    Phytomedicine; 2023 Apr 15; 112():154700. PubMed ID: 36774842
    [Abstract] [Full Text] [Related]

  • 12. Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K/Akt/mTOR signals.
    Tang G, Du Y, Guan H, Jia J, Zhu N, Shi Y, Rong S, Yuan W.
    Br J Pharmacol; 2022 Jan 15; 179(1):159-178. PubMed ID: 34638162
    [Abstract] [Full Text] [Related]

  • 13. Ameliorative effects of Modified Huangqi Chifeng decoction on podocyte injury via autophagy mediated by PI3K/AKT/mTOR and AMPK/mTOR pathways.
    Zhao M, Yin Y, Yang B, Chang M, Ma S, Shi X, Li Q, Li P, Zhang Y.
    J Ethnopharmacol; 2024 Mar 01; 321():117520. PubMed ID: 38042389
    [Abstract] [Full Text] [Related]

  • 14. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
    Wang X, Gao L, Lin H, Song J, Wang J, Yin Y, Zhao J, Xu X, Li Z, Li L.
    Eur J Pharmacol; 2018 Apr 05; 824():170-178. PubMed ID: 29444469
    [Abstract] [Full Text] [Related]

  • 15. Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway.
    Chen J, Yuan S, Zhou J, Huang X, Wu W, Cao Y, Liu H, Hu Q, Li X, Guan X, Yin S, Jiang J, Zhou Y, Zhou J.
    Phytomedicine; 2022 Dec 05; 107():154477. PubMed ID: 36215790
    [Abstract] [Full Text] [Related]

  • 16. Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway.
    Wang X, Jiang L, Liu XQ, Huang YB, Wang AL, Zeng HX, Gao L, Zhu QJ, Xia LL, Wu YG.
    Phytomedicine; 2022 Nov 05; 106():154400. PubMed ID: 36049428
    [Abstract] [Full Text] [Related]

  • 17. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M, Li Y, Wang L, Guo B, Mei W, Zhu B, Zhang J, Ding Y, Meng B, Zhang L, Xiang L, Dong J, Liu M, Xiang L, Xiang G.
    Diabetologia; 2020 Sep 05; 63(9):1916-1931. PubMed ID: 32588068
    [Abstract] [Full Text] [Related]

  • 18. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z, Liang W, Luo Q, Hu H, Yang K, Hu J, Chen Z, Zhu J, Feng J, Zhu Z, Chi Q, Ding G.
    Front Endocrinol (Lausanne); 2021 Sep 05; 12():797025. PubMed ID: 35095764
    [Abstract] [Full Text] [Related]

  • 19. P2X7R/AKT/mTOR signaling mediates high glucose-induced decrease in podocyte autophagy.
    Qian C, Lu J, Che X, Min L, Wang M, Song A, Lu R, Gu L, Xie K.
    Free Radic Biol Med; 2023 Aug 01; 204():337-346. PubMed ID: 37245531
    [Abstract] [Full Text] [Related]

  • 20. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
    Salemkour Y, Yildiz D, Dionet L, 't Hart DC, Verheijden KAT, Saito R, Mahtal N, Delbet JD, Letavernier E, Rabant M, Karras A, van der Vlag J, Nijenhuis T, Tharaux PL, Lenoir O.
    J Am Soc Nephrol; 2023 Nov 01; 34(11):1823-1842. PubMed ID: 37678257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.